Increased oxidative stress in patients with amyotrophic lateral sclerosis and the effect of edaravone administration

Redox Report

Volumn 21, Issue 3, 2016, Pages 104-112

  Nagase, Midori ^a   Yamamoto, Yorihiro ^a   Miyazaki, Yusuke ^a   Yoshino, Hiide ^b  

^a TOKYO UNIVERSITY OF TECHNOLOGY   (Japan)

^b Yoshino Neurology Clinic   (Japan)

Author keywords

Coenzyme Q10 redox balance; Edaravone treatment; Peroxynitrite; Plasma free fatty acid composition; Uric acid

Indexed keywords

FATTY ACID; NORPHENAZONE; OLEIC ACID; PALMITOLEIC ACID; PEROXYNITRITE; POLYUNSATURATED FATTY ACID; UBIDECARENONE; URIC ACID; BIOLOGICAL MARKER; PEROXYNITROUS ACID; PHENAZONE; PHENYLMETHYLPYRAZOLONE; SCAVENGER; UBIQUINONE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MALE; MIDDLE AGED; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; TISSUE INJURY; TREATMENT OUTCOME; URIC ACID BLOOD LEVEL; AGED; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; DRUG EFFECTS; METABOLISM;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTIPYRINE; BIOMARKERS; FATTY ACIDS, NONESTERIFIED; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXYNITROUS ACID; UBIQUINONE; URIC ACID;

EID: 84978698157     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000215Y.0000000026     Document Type: Article

References (26)

1. L.P.Rowland, N.A.Shneider. Amyotrophic lateral sclerosis. N Engl J Med 2001;344:1688–700. doi: 10.1056/NEJM200105313442207
2. A.Chio, G.Logroscino, O.Hardiman, R.Swingler, D.Mitchell, E.Beghi, Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 2009;10:310–23. doi: 10.3109/17482960802566824
3. S.C.Barber, R.J.Mead, P.J.Shaw. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 2006;1762:1051–67. doi: 10.1016/j.bbadis.2006.03.008
4. M.F.Beal, R.J.Ferrante, S.E.Browne, R.T.Matthews, N.W.Kowall, R.H.Brown, Jr. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 1997;42:644–54. doi: 10.1002/ana.410420416
5. R.J.Ferrante, S.E.Browne, L.A.Shinobu, A.C.Bowling, M.J.Baik, U.MacGarvey, Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997;69:2064–74. doi: 10.1046/j.1471-4159.1997.69052064.x
6. P.Pacher, J.S.Beckman, L.Liaudet. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315–424. doi: 10.1152/physrev.00029.2006
7. H.Tohgi, T.Abe, K.Yamazaki, T.Murata, E.Ishizaki, C.Isobe. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann Neurol 1999;46:129–31. doi: 10.1002/1531-8249(199907)46:1<129::AID-ANA21>3.0.CO;2-Y
8. M.Sohmiya, M.Tanaka, Y.Suzuki, Y.Tanino, K.Okamoto, Y.Yamamoto. An increase of oxidized coenzyme Q-10 occurs in the plasma of sporadic ALS patients. J Neurol Sci 2005;228:49–53. doi: 10.1016/j.jns.2004.09.030
9. Edaravone Acute Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction: randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003;15:222–9. doi: 10.1159/000069318
10. Y.Yamamoto, T.Kuwahara, K.Watanabe, K.Watanabe. Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186). Redox Rep 1996;2:333–8.
11. H.Yoshino, A.Kimura. Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study). Amyotroph Lateral Scler 2006;7:241–5. doi: 10.1080/17482960600664870
12. S.Yamashita, Y.Yamamoto. Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Anal Biochem 1997;250:66–73. doi: 10.1006/abio.1997.2187
13. Y.Yamamoto, B.N.Ames. Detection of lipid hydroperoxides and hydrogen peroxide at picomole levels by an HPLC and isoluminol chemiluminescence assay. Free Radic Biol Med 1987;3:359–61. doi: 10.1016/S0891-5849(87)80048-5
14. Y.Yamamoto, Y.Nagata, M.Katsurada, S.Sato, Y.Ohori. Changes in rat plasma free fatty acids composition under oxidative stress induced by carbon tetrachloride: decrease of polyunsaturated fatty acids and increase of palmitoleic acid. Redox Rep 1996;2:121–5.
15. H.Wada, S.Hagiwara, H.Goto, Y.Yamamoto. Redox status of coenzyme Q10 is associated to chronological age. J Am Geriatr Soc 2007;55:1141–2. doi: 10.1111/j.1532-5415.2007.01209.x
16. H.Wada, S.Hagiwara, E.Saitoh, E.Ieki, Y.Yamamoto, I.M.Adcock, Up-regulation of blood arachidonate (20:4) levels in patients with chronic obstructive pulmonary disease, Biomarkers 2012;17:520–3. doi: 10.3109/1354750X.2012.692393
17. D.Keizman, M.Ish-Shalom, S.Berliner, N.Maimon, Y.Vered, I.Artamonov, Low uric acid levels in serum of patients with ALS: further evidence for oxidative stress? J Neurol Sci 2009;285:95–9. doi: 10.1016/j.jns.2009.06.002
18. R.Stocker, Y.Yamamoto, A.F.McDonagh, A.N.Glazer, B.N.Ames. Bilirubin is an antioxidant of possible physiological importance. Science 1987;235:1043–6. doi: 10.1126/science.3029864
19. J.M.C.Gutteridge, G.J.Quinlan, Y.Yamamoto. Are fatty acid patterns characteristic of essential fatty acid deficiency indicative of oxidative stress? Free Radic Res 1998;28:109–14. doi: 10.3109/10715769809065796
20. G.J.Quinlan, N.J.Lamb, T.W.Evans, J.M.C.Gutteridge. Plasma fatty acid changes and increased lipid peroxidation in patients with adult respiratory distress syndrome. Crit Care Med 1996;24:241–6. doi: 10.1097/00003246-199602000-00010
21. W.C.Love, A.Cashell, M.Reynolds, N.Callaghan. Linoleate and fatty-acid patterns of serum lipids in multiple sclerosis and other diseases. Br Med J 1974;6:18–21. doi: 10.1136/bmj.3.5922.18
22. M.Battino, M.S.Ferreiro, J.L.Quiles, S.Bompadre, L.Leone, P.Bullon. Alterations in the oxidation products, antioxidant markers, antioxidant capacity and lipid patterns in plasma of patients affected by Papillon–Lefevre syndrome. Free Radic Res 2003;37:603–9. doi: 10.1080/1071576031000083116
23. T.Miyamae, M.Seki, T.Naga, S.Uchino, H.Asazuma, T.Yoshida, Increased oxidative stress and coenzyme Q10 deficiency in juvenile fibromyalgia: amelioration of hypercholesterolemia and fatigue by ubiquinol-10 supplementation, Redox Rep 2013;18:12–9. doi: 10.1179/1351000212Y.0000000036
24. K.Hara, S.Yamashita, A.Fujisawa, T.Ogawa, Y.Yamamoto. Oxidative stress in newborn infants with and without asphyxia as measured by plasma antioxidants and free fatty acids. Biochem Biophys Res Commun 1999;257:244–8. doi: 10.1006/bbrc.1999.0436
25. Y.Yamamoto, M.Yanagisawa, N.W.Tak, K.Watanabe, C.Takahashi, A.Fujisawa, Repeated edaravone treatment reduces oxidative cell damage in rat brain induced by middle cerebral artery occlusion. Redox Rep 2009;14:251–8. doi: 10.1179/135100009X12525712409779
26. A.Fujisawa, Y.Yamamoto. Edaravone, a potent free radical scavengerat, reacts with peroxynitrite to produce predominantly the 4-NO-edaravone. Redox Rep, 2015;[Epub ahead of print].